The oral treatment of urinary schistosomiasis in Egyptian patients with 'Oltipraz'.
Oltipraz was given in a daily dose of 1.5 gm for two days to 40 patients with haematobiasis. Cure rates of 92.5% and 82.5% were obtained after two and six months follow-up examinations. A high proportion of egg-reduction of 97% and 98% was obtained in 'egg-positive' cases. Clinical and biological tolerance of patients to the drug was excellent. The drug is easy in administration, given orally and with minimal side effects.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D005500:Follow-Up Studies; D006801:Humans; D010270:Parasite Egg Count; D011719:Pyrazines / Q000627:therapeutic use*; D012548:Schistosoma haematobium / Q000187:drug effects; D012552:Schistosomiasis / Q000188:drug therapy* / Q000469:parasitology; D012556:Schistosomicides / Q000627:therapeutic use*; D013871:Thiones; D013876:Thiophenes; D014570:Urologic Diseases / Q000188:drug therapy* / Q000469:parasitology
D011719:Pyrazines; D012556:Schistosomicides; D013871:Thiones; D013876:Thiophenes; C026209:oltipraz